4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-041639
President and CEO acquired 814 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2022-06-30 | Grant or award | +814 | $14.24 | $11,591 | 254,554 | D |
Loading xslF345X03/doc4.xml…